KNWN
Know Labs, Inc. [KNWN] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
KNWN Stock Summary
In the News
KNWN Financial details
Company Rating
Neutral
Market Cap
130.64M
Income
-30.12M
Revenue
4.36M
Book val./share
0.11
Cash/share
0.19
Dividend
-
Dividend %
-
Employees
15
Optionable
No
Shortable
Yes
Earnings
12 Aug 2022
P/E
-9.35
Forward P/E
-
PEG
-2.59
P/S
15038.96
P/B
24.11
P/C
14.26
P/FCF
-58.28
Quick Ratio
1.82
Current Ratio
1.82
Debt / Equity
0.51
LT Debt / Equity
0.02
-
-
EPS (TTM)
-0.84
EPS next Y
-
EPS next Q
-
EPS this Y
38.71%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-3.16%
Revenue last 5Y
-100%
Revenue Q/Q
-
EPS Q/Q
-70.36%
-
-
-
-
SMA20
-
SMA50
-50%
SMA100
-
Inst Own
3.71%
Inst Trans
1.32%
ROA
-132%
ROE
-218%
ROC
-1.12%
Gross Margin
-3567%
Oper. Margin
-64536%
Profit Margin
-145986%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
-
52W High
-
52W Low
-
RSI
46
Rel Volume
-
Avg Volume
-
Volume
409.44K
Perf Week
102.24%
Perf Month
97.81%
Perf Quarter
-
Perf Half Y
0%
-
-
-
-
Beta
2.37475
-
-
Volatility
0.49%, 0.25%
Prev Close
111.72%
Price
2.71
Change
108.46%
KNWN Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-09-30
| Metric | History | 2017-09-30 | 2018-09-30 | 2019-09-30 | 2020-09-30 | 2021-09-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 1.27 | 0.5 | 0.1 | 0.01 | 0 | |
| Net income per share | -1.01 | -0.38 | -0.42 | -0.62 | -0.86 | |
| Operating cash flow per share | -0.33 | -0.13 | -0.17 | -0.18 | -0.23 | |
| Free cash flow per share | 0.31 | -0.13 | -0.18 | -0.18 | -0.24 | |
| Cash per share | 0.03 | 0.11 | 0.11 | 0.2 | 0.42 | |
| Book value per share | -1.03 | -0.3 | -0.18 | -0.09 | 0.04 | |
| Tangible book value per share | -1.03 | -0.35 | -0.2 | -0.09 | 0.04 | |
| Share holders equity per share | -1.03 | -0.3 | -0.18 | -0.09 | 0.04 | |
| Interest debt per share | 0.55 | 0.42 | 0.4 | 0.48 | 0.85 | |
| Market cap | 6.54M | 14.67M | 30.69M | 37.04M | 49.93M | |
| Enterprise value | 8.17M | 16.14M | 32.99M | 37.07M | 47.59M | |
| P/E ratio | -1.68 | -4.5 | -4.03 | -2.73 | -1.97 | |
| Price to sales ratio | 1.34 | 3.41 | 17 | 303.8 | 0 | |
| POCF ratio | -5.17 | -13.13 | -9.89 | -9.47 | -7.29 | |
| PFCF ratio | 5.55 | -13.13 | -9.64 | -9.3 | -6.98 | |
| P/B Ratio | -1.65 | -5.63 | -9.31 | -19.35 | 40.2 | |
| PTB ratio | -1.65 | -5.63 | -9.31 | -19.35 | 40.2 | |
| EV to sales | 1.68 | 3.75 | 18.28 | 304.02 | 0 | |
| Enterprise value over EBITDA | -2.37 | -8.36 | -7.48 | -5.13 | -4.64 | |
| EV to operating cash flow | -6.46 | -14.45 | -10.63 | -9.47 | -6.95 | |
| EV to free cash flow | 6.94 | -14.45 | -10.36 | -9.31 | -6.66 | |
| Earnings yield | -0.6 | -0.22 | -0.25 | -0.37 | -0.51 | |
| Free cash flow yield | 0.18 | -0.08 | -0.1 | -0.11 | -0.14 | |
| Debt to equity | -0.44 | -0.92 | -1.27 | -2.26 | 7.98 | |
| Debt to assets | 1.46 | 1.14 | 1.59 | 0.92 | 0.77 | |
| Net debt to EBITDA | -0.47 | -0.76 | -0.52 | 0 | 0.23 | |
| Current ratio | 0.2 | 0.31 | 0.34 | 0.65 | 1.07 | |
| Interest coverage | -8.6 | -1.89 | -1.7 | -1.12 | -0.7 | |
| Income quality | 0.32 | 0.34 | 0.41 | 0.29 | 0.27 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0.02 | 0.13 | 0.7 | 16.68 | 0 | |
| Intangibles to total assets | 0 | 0.21 | 0.1 | 0.02 | 0 | |
| Capex to operating cash flow | -1.93 | 0 | 0.03 | 0.02 | 0.04 | |
| Capex to revenue | 0.5 | 0 | -0.04 | -0.58 | 0 | |
| Capex to depreciation | 30.03 | 0 | -0.31 | -0.29 | -1.49 | |
| Stock based compensation to revenue | 0.01 | 0.07 | 0.7 | 13.96 | 0 | |
| Graham number | 4.85 | 1.6 | 1.32 | 1.11 | 0.91 | |
| ROIC | 1.35 | 11.54 | -4.56 | -2.56 | -0.91 | |
| Return on tangible assets | -3.28 | -1.97 | -3.22 | -2.96 | -1.97 | |
| Graham Net | -1.15 | -0.4 | -0.22 | -0.11 | 0.02 | |
| Working capital | -4.1M | -3.23M | -3.84M | -2.28M | 789.06K | |
| Tangible asset value | -3.96M | -3.06M | -3.57M | -2.02M | 1.24M | |
| Net current asset value | -4.1M | -3.23M | -3.96M | -2.3M | 610.89K | |
| Invested capital | -0.44 | -0.92 | -1.27 | -2.26 | 7.98 | |
| Average receivables | 751.14K | 506.93K | 191.79K | 31.52K | 0 | |
| Average payables | 2.07M | 1.84M | 1.17M | 655.74K | 456.3K | |
| Average inventory | 260.56K | 214.75K | 105.34K | 3.55K | 0 | |
| Days sales outstanding | 51.92 | 27.19 | 12.75 | 0 | 0 | |
| Days payables outstanding | 198.45 | 159.83 | 216.6 | 2.58K | 0 | |
| Days of inventory on hand | 20.79 | 21.34 | 1.88 | 0 | 0 | |
| Receivables turnover | 7.03 | 13.43 | 28.63 | 0 | 0 | |
| Payables turnover | 1.84 | 2.28 | 1.69 | 0.14 | 0 | |
| Inventory turnover | 17.56 | 17.1 | 194.06 | 0 | 0 | |
| ROE | 0.98 | 1.25 | 2.31 | 7.08 | -20.42 | |
| Capex per share | 0.63 | 0 | 0 | 0 | -0.01 |
Quarterly Fundamentals Overview
Last date of statement is 2022-06-30 for Q3
| Metric | History | 2021-06-30 | 2021-09-30 | 2021-12-31 | 2022-03-31 | 2022-06-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0 | 0 | 0.12 | 0 | 0 | |
| Net income per share | -0.23 | -0.24 | -0.28 | -0.25 | -0.07 | |
| Operating cash flow per share | -0.06 | -0.05 | -0.05 | 0.02 | -0.06 | |
| Free cash flow per share | -0.06 | -0.06 | -0.06 | 0.01 | -0.06 | |
| Cash per share | 0.45 | 0.39 | 0.3 | 0.3 | 0.19 | |
| Book value per share | 0.19 | 0.04 | -0.09 | 0.18 | 0.11 | |
| Tangible book value per share | 0.19 | 0.04 | -0.09 | 0.18 | 0.11 | |
| Share holders equity per share | 0.19 | 0.04 | -0.09 | 0.18 | 0.11 | |
| Interest debt per share | 0.34 | 0.49 | 0.53 | 0.17 | 0.06 | |
| Market cap | 52.79M | 52.79M | 60.31M | 71.58M | 103.39M | |
| Enterprise value | 44.39M | 50.44M | 63.73M | 63.37M | 97.53M | |
| P/E ratio | -1.86 | -1.74 | -1.53 | -1.9 | -7.97 | |
| Price to sales ratio | 0 | 0 | 13.86 | 8.24K | 0 | |
| POCF ratio | -27.83 | -30.94 | -31.61 | 80.81 | -38.73 | |
| PFCF ratio | -27.64 | -26.96 | -26.3 | 161.09 | -38.49 | |
| P/B Ratio | 8.8 | 42.5 | -19.2 | 10.64 | 21.02 | |
| PTB ratio | 8.8 | 42.5 | -19.2 | 10.64 | 21.02 | |
| EV to sales | 0 | 0 | 14.65 | 7.3K | 0 | |
| Enterprise value over EBITDA | -24.31 | -21.17 | -76.97 | -22.91 | -36.63 | |
| EV to operating cash flow | -23.4 | -29.57 | -33.4 | 71.55 | -36.54 | |
| EV to free cash flow | -23.24 | -25.76 | -27.79 | 142.63 | -36.31 | |
| Earnings yield | -0.13 | -0.14 | -0.16 | -0.13 | -0.03 | |
| Free cash flow yield | -0.04 | -0.04 | -0.04 | 0.01 | -0.03 | |
| Debt to equity | 0.91 | 7.98 | -4.5 | 0.44 | 0.51 | |
| Debt to assets | 0.39 | 0.77 | 0.95 | 0.24 | 0.26 | |
| Net debt to EBITDA | 4.6 | 0.98 | -4.12 | 2.97 | 2.2 | |
| Current ratio | 1.77 | 1.07 | 0.8 | 2.11 | 1.82 | |
| Interest coverage | -0.36 | -0.47 | -0.19 | -0.86 | -11.53 | |
| Income quality | 0.27 | 0.22 | 0.36 | -0.14 | 0.89 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | -716.35 | -17.62K | 0 | |
| Research and developement to revenue | 0 | 0 | 0.2 | 143.74 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0.01 | 0.15 | 0.2 | -0.5 | 0.01 | |
| Capex to revenue | 0 | 0 | -0.09 | -50.82 | 0 | |
| Capex to depreciation | -0.34 | -7.26 | -9.25 | -5.78 | -0.16 | |
| Stock based compensation to revenue | 0 | 0 | 0.05 | 49.78 | 0 | |
| Graham number | 1 | 0.47 | 0.74 | 1 | 0.43 | |
| ROIC | -0.16 | -0.21 | -0.14 | -0.44 | -0.39 | |
| Return on tangible assets | -0.51 | -0.59 | -0.66 | -0.75 | -0.34 | |
| Graham Net | 0.19 | 0.02 | -0.14 | 0.14 | 0.08 | |
| Working capital | 6.05M | 789.06K | -3.56M | 5.94M | 3.79M | |
| Tangible asset value | 6M | 1.24M | -3.14M | 6.73M | 4.92M | |
| Net current asset value | 5.84M | 610.89K | -4.17M | 5.37M | 3.69M | |
| Invested capital | 0.91 | 7.98 | -4.5 | 0.44 | 0.51 | |
| Average receivables | 0 | 0 | 1.56M | 1.62M | 82.68K | |
| Average payables | 419.76K | 412.02K | 413.8K | 410.19K | 408.64K | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 0 | 0 | 64.63 | 1.24K | 0 | |
| Days payables outstanding | 0 | 0 | 11.79 | 239.92 | 222.36 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 0 | 0 | 1.39 | 0.07 | 0 | |
| Payables turnover | 0 | 0 | 7.63 | 0.38 | 0.4 | |
| Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
| ROE | -1.18 | -6.12 | 3.13 | -1.4 | -0.66 | |
| Capex per share | 0 | -0.01 | -0.01 | -0.01 | 0 |
KNWN Frequently Asked Questions
What is Know Labs, Inc. stock symbol ?
Know Labs, Inc. is a US stock , located in Seattle of Wa and trading under the symbol KNWN
What is Know Labs, Inc. stock quote today ?
Know Labs, Inc. stock price is $2.71 today.
Is Know Labs, Inc. stock public?
Yes, Know Labs, Inc. is a publicly traded company.
Company Profile
- Market Capitalization 130.64M
- Employee 15
- CEO Mr. Ronald P. Erickson
- Headquarters Seattle,WA,US
- IPO Date 2006-04-18
-
Website
https://www.knowlabs.co 
Know Labs, Inc. focuses on the development and commercialization of proprietary technologies in the United States. Its technology uses spectroscopy to direct electromagnetic energy through a substance or material to capture a molecular signature. The company refers to its technology as Bio-RFID. The Bio-RFID technology can be integrated into various wearable, mobile, or bench-top form factors. Its first application of Bio-RFID technology is a product marketed as a glucose monitor that provide the user with real time information on their blood glucose levels. The company was formerly known as Visualant, Incorporated and changed its name to Know Labs, Inc. in May 2018. Know Labs, Inc. was founded in 1998 and is headquartered in Seattle, Washington.
